Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2002

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2002. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Linda Ann Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Web site located at http://www.fda.gov/​oc/​advisory/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2002. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area):

Start Printed Page 333
Committee NameDates of MeetingsAdvisory Committee 5-Digit Information Line Code
OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug AdministrationApril 16, November 1212603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeMarch 15, November 412388
Biological Response Modifiers Advisory CommitteeFebruary 28-March 1 (Alternate: January 30-31), July 18-19 (Alternate: May 9-10), November 7-8 (Alternate: October 10-11).12389
Blood Products Advisory CommitteeMarch 14-15, June 13-14, September 12-13, December 12-13.19516
Transmissible Spongiform Encephalopathies Advisory Committee.January 16-17, June 26-27, October 17-1812932
Vaccines and Related Biological Products Advisory CommitteeJanuary 30-31, March 6-7, May 21-22, July 10-11, September 10-11, November 18-19.12391
CENTER FOR DRUG EVALUATION AND RESEARCH
Advisory Committee for Pharmaceutical ScienceFebruary 25-26, May 7-9, October 23-2512539
Advisory Committee for Reproductive Health DrugsSeptember 1312537
Anesthetic and Life Support Drugs Advisory CommitteeJanuary 30-31, April 11-1212529
Anti-Infective Drugs Advisory CommitteeFebruary 19-2012530
Antiviral Drugs Advisory CommitteeJanuary 24, March 19, June 24-25, October 16-17.12531
Arthritis Advisory CommitteeFebruary 19-20, May 14-15, July 29-30, September 12-13, December 10-11.12532
Cardiovascular and Renal Drugs Advisory CommitteeJanuary 17-18, April 11-12, July 18-19, October 10-11.12533
Dermatologic and Ophthalmic Drugs Advisory CommitteeSeptember 2012534
Drug Abuse Advisory CommitteeNo meetings planned12535
Endocrinologic and Metabolic Drugs Advisory CommitteeMarch 14-15, May 23-24, July 22-23, September 26-27, December 5-6.12536
Gastrointestinal Drugs Advisory CommitteeSeptember 2712538
Medical Imaging Drugs Advisory CommitteeApril 18, August 1512540
Nonprescription Drugs Advisory CommitteeApril 22-2312541
Oncologic Drugs Advisory CommitteeJanuary 31, February 27-28, June 6-712542
Peripheral and Central Nervous System Drugs Advisory Committee.February 1512543
Pharmacy Compounding Advisory CommitteeSeptember 2712440
Psychopharmacologic Drugs Advisory CommitteeSeptember 1312544
Pulmonary-Allergy Drugs Advisory CommitteeJanuary 17-18, May 16-1712545
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeJune 4-5, September 24-2510564
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeNo meetings planned12398
Medical Devices Advisory Committee:
Start Printed Page 334
Anesthesiology and Respiratory Therapy Devices PanelMarch 18, May 13, September 23, October 2812624
Circulatory System Devices PanelMarch 4-5, June 3-4, September 9-10, November 4-5, December 2-3.12625
Clinical Chemistry and Clinical Toxicology Devices PanelFebruary 11-12, May 23-24, August 19-20, November 8.12514
Dental Products PanelMay 9-10, August 22-23, October 29-3012518
Ear, Nose, and Throat Devices PanelFebruary 21-22, April 25-26, June 20-21, August 15-16, October 17-18, December 12-13.12522
Gastroenterology and Urology Devices PanelFebruary 1, May 17, August 9, November 712523
General and Plastic Surgery Devices PanelFebruary 7-8, April 9-10, July 8-9, October 1-212519
General Hospital and Personal Use Devices PanelMarch 11-12, June 10-11, September 9-10, December 5-6.12520
Hematology and Pathology Devices PanelApril 15-16, June 17-18, September 26-2712515
Immunology Devices PanelMarch 15, June 14, September 13, December 612516
Medical Devices Dispute Resolution PanelAs needed10232
Microbiology Devices PanelFebruary 21-22, May 9-10, September 19-20, October 28-29.12517
Molecular and Clinical Genetics PanelApril 19, July 26, November 110231
Neurological Devices PanelFebruary 25-26, May 9-10, August 1-2, November 21-22.12513
Obstetrics and Gynecology Devices PanelApril 22-23, July 22-23, October 21-2212524
Ophthalmic Devices PanelJanuary 17-18, March 14-15, May 16-17, July 18-19, September 12-13, November 14-15.12396
Orthopaedic and Rehabilitation Devices PanelJanuary 10, April 11-12, July 11-12, October 17-18.12521
Radiological Devices PanelFebruary 4, May 20, August 12, November 1812526
National Mammography Quality Assurance Advisory CommitteeMay 6, September 2312397
Technical Electronic Product Radiation Safety Standards Committee.May 1512399
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeJanuary 22-24, September 1612548
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants.March 13-14, September 24-2512560
Science Advisory Board to the National Center for Toxicological Research.June 11-1212559
Start Signature
Start Printed Page 335

Dated: December 26, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

End Signature End Supplemental Information

[FR Doc. 02-26 Filed 1-2-02; 8:45 am]

BILLING CODE 4160-02-S